2024
- LATEST
- 2023
- 2022
- 2021
- ARCHIVE
-
34th Ordinary General Meeting of Shareholders
-
FY2023 Financial Results Presentation
-
42nd Annual J.P. Morgan Healthcare Conference
-
Jefferies London Healthcare Conference 2023
-
R&D Day
-
H1 FY2023 Financial Results
-
Acquisition of Idorsia’s Pharmaceuticals Business in Japan and APAC (ex China)
-
33rd Ordinary General Meeting of Shareholders
-
Top Interview - Stock Voice TV (Japanese only)
-
FY2022 Financial Results Presentation
-
41st J.P. Morgan Healthcare Conference
-
Jefferies London Healthcare Conference
-
IR seminar for individual investors (Japanese only) - Sosei's Business Overview
-
R&D Day
-
IR seminar for individual investors (Japanese only) - Intrroduction for Biotechnology Sector
-
H1 FY2022 Financial Results Presentation
-
32nd Ordinary General Meeting of Shareholders
-
FY2021 Financial Results Presentation
-
40th Annual J.P. Morgan Healthcare Conference
-
Investor Webinar Q&A; - Collaboration with Neurocrine Biosciences to Develop Novel Muscarinic Receptor Agonists
-
Collaboration with Neurocrine Biosciences to Develop Novel Muscarinic Receptor Agonists
-
Jefferies London Healthcare Conference 2021 Presentation
-
H1 FY2021 Financial Results Presentation
-
UBS Global Healthcare Virtual Conference 2021
-
Online briefing session for investors (in Japanese)
-
31st Ordinary General Meeting of Shareholders
-
FY2020 Financial Results Conference Call
-
FY2020 Financial Results Presentation
-
39th Annual J.P. Morgan Healthcare Conference
-
Regains Muscarinic Agonist Programs
-
Coronavirus Program Update
-
H1 FY2020 Financial Results Presentation
-
New Discovery Collaboration With AbbVie (Japanese only)
-
30th Ordinary General Meeting of Shareholders
-
FY2019 Financial Results Presentation
-
38th Annual J.P. Morgan Healthcare Conference
-
Investor R&D Day Presentation - Malcolm Weir, EVP Chief R&D Officer
-
Investor R&D Day Presentation - Chris de Graaf Director, Head of Computational Chemistry
-
Investor R&D Day Presentation - Stacey Southall Associate Director, Head of Biophysics
-
Investor R&D Day Presentation - Rie Suzuki - Director, Translational Sciences
-
Investor R&D Day Presentation - Professor Yoshinori Fujiyoshi (Japanese Only)
-
Investor R&D Day Webcast
-
H1 FY2019 Financial Results Presentation
-
Individual Shareholders Briefing (Japanese only)
-
29th Ordinary General Meeting of Shareholders
-
Individual Shareholders Briefing (Japanese only)
-
FY2018 Financial Results (Nine-month period ended December 31, 2018) Presentation (with note)
-
FY2018 Financial Results (Nine-month period ended December 31, 2018) Presentation